Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.42 |
| ▸ | MME | P08473 | 5/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | QRFPR | Q96P65 | 3/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.37 |
| ▸ | NMT2 | O60551 | 2/20 | 0.36 |
| ▸ | NMT1 | P30419 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29542622 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL31187165 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL31219378 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL31187142 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL6749006 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL6749004 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL32669039 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL17874144 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL1635449 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 | |
| SCHEMBL29530559 | 1.00 | TGFBR1 (0.42) | TGFBR1MMETERTQRFPRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630960-B1 | METHOD FOR PREPARING PHOSPHORYLATED KETO POLYOLS, DERIVATIVES THEREOF AND USES THEREOF | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2023-12-13 | — | — | EP | disclosed |
| US-11466298-B2 | Method for preparing phosphorylated keto polyols, derivatives thereof and uses thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2022-10-11 | — | — | US | disclosed |
| US-20210317165-A1 | ZP3 FRAGMENTS IN IMMUNOTHERAPY OF OVARIAN CANCER | LABORATOIRE HRA-PHARMA (FR) | 2021-10-14 | — | — | US | disclosed |
| US-11118200-B2 | Method for preparing amines from aldehydes and ketones by biocatalysis | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2021-09-14 | — | — | US | disclosed |
| EP-3847187-A1 | ZP3 FRAGMENTS IN IMMUNOTHERAPY OF OVARIAN CANCER | Laboratoire HRA-Pharma (FR) | 2021-07-14 | — | — | EP | disclosed |
| US-20200224225-A1 | METHOD FOR PREPARING AMINES FROM ALDEHYDES AND KETONES BY BIOCATALYSIS | UNIVERSITE D'EVRY VAL D'ESSONNE (UEVE) (FR) | 2020-07-16 | — | — | US | disclosed |
| US-20200208181-A1 | METHOD FOR PREPARING PHOSPHORYLATED KETO POLYOLS, DERIVATIVES THEREOF AND USES THEREOF | UNIVERSITE D'EVRY VAL D'ESSONNE (FR) | 2020-07-02 | — | — | US | disclosed |
| EP-3649246-A1 | METHOD FOR PREPARING AMINES FROM ALDEHYDES AND KETONES BY BIOCATALYSIS | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2020-05-13 | — | — | EP | disclosed |
| EP-3630960-A1 | METHOD FOR PREPARING PHOSPHORYLATED KETO POLYOLS, DERIVATIVES THEREOF AND USES THEREOF | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2020-04-08 | — | — | EP | disclosed |
| WO-2019073011-A1 | ENZYMATIC SYNTHESIS OF LIPOLANTHIPEPTIDES | DEINOVE (FR) | 2019-04-18 | — | — | WO | disclosed |
| WO-2019008110-A1 | METHOD FOR PREPARING AMINES FROM ALDEHYDES AND KETONES BY BIOCATALYSIS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2019-01-10 | — | — | WO | disclosed |
| WO-2018215476-A1 | METHOD FOR PREPARING PHOSPHORYLATED KETO POLYOLS, DERIVATIVES THEREOF AND USES THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2018-11-29 | — | — | WO | disclosed |
| WO-2015189162-A1 | SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST A CYS-LOOP RECEPTOR AND METHODS FOR OBTAINING THEM | THERANYX (FR) | 2015-12-17 | — | — | WO | disclosed |
| WO-2015078889-A1 | NEW ENZYMES AND METHOD FOR PREPARING HYDROXYLATED L-LYSINE OR L-ORNITHINE AND ANALOGS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-06-04 | — | — | WO | disclosed |
| EP-2876156-A1 | New enzymes and method for preparing hydroxylated L-lysine or L-ornithine and analogs thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11466298-B2 | Method for preparing phosphorylated keto polyols, derivatives thereof and uses thereof | PHYKPL, PNKP, PCK1 | TGFBR1 4882/4885MME 3339/4885TERT 2724/4885 |
| US-20200208181-A1 | METHOD FOR PREPARING PHOSPHORYLATED KETO POLYOLS, DERIVATIVES THEREOF AND USES THEREOF | PHYKPL, PNKP, PCK1 | TGFBR1 4882/4885MME 3339/4885TERT 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.